Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pilot study of unrelated umbilical cord blood transplantation with third-party mesenchymal stem cell coinfusion in adult hematological malignancies
2009-011817-26Phase 2Completed
- Sponsor
- UZ Brussel
- Start
- Sep 2009
- Modality
- Stem Cell Therapies → Cell Therapies
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of mesenchymal stem cells in hematopoietic malignancies, sponsored by UZ Brussel. Primary endpoint: Treatment-related mortality at day 100 post-transplant. Started Sep 2009; status: completed.
02
Drugs
mesenchymal stem cells
03
Conditions
hematopoietic malignancies
Beyond the preview
Go deeper on 2009-011817-26.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-011817-26.